Browsing Tag
Jayson Dallas
4 posts
Nestlé to fully own Aimmune Therapeutics through $2bn deal
Nestlé will take full ownership of Aimmune Therapeutics, the developer of FDA approved peanut allergy drug Palforzia, by…
September 1, 2020
First patients being treated with Aimmune’s PALFORZIA peanut allergy drug
Aimmune Therapeutics said that the first patients in the US are being treated with the recently FDA approved…
March 17, 2020
Nestlé increases stake in Aimmune Therapeutics after Palforzia FDA approval
Aimmune Therapeutics, which has recently bagged approval from the US Food and Drug Administration (FDA) for its peanut…
February 9, 2020
Aimmune Therapeutics bags Palforzia FDA approval for peanut allergy
Palforzia FDA approval : Aimmune Therapeutics has been granted approval from the US Food and Drug Administration (FDA)…
February 3, 2020